The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.
Open accessAbstract
Recently, angiotensin II (Ang II) has been shown to cause hypertrophy of cultured quiescent rat aortic smooth muscle (RASM) cells. This observation along with the demonstration of angiotensinogen mRNA in the vessel wall has led us to postulate a role for vascular angiotensin in hypertensive blood vessel hypertrophy. To investigate further the possible molecular mechanisms, we examined the effect of Ang II on the expression of two genes known to be involved with cellular growth response. Near-confluent RASM cells were made quiescent by 48-h exposure to a defined serum-free medium. Ang II (10(-6) to 10(-11) M) resulted in an induction of the protooncogene c-myc mRNA within 30 min which persisted for 6 h. Interestingly, 6 h after the addition of Ang II, platelet-derived growth factor (PDGF) A-chain mRNA expression was elevated, peaked in 9 h, and persisted for 11 h. This was accompanied with a 15-20-fold increase in PDGF concentration in the culture medium. These effects were dose-dependent and were blocked by saralasin. Whereas the inhibition of protein synthesis by cycloheximide resulted in a stabilization of c-myc mRNA, cycloheximide abolished the elevation of the PDGF A-chain mRNA. Taken together, our data show that exposure of RASM cells to Ang II results in the sequential activation of c-myc and PDGF A-chain mRNA expressions. This sequential activation of protooncogene and growth factor gene may be an important mechanism in angiotensin-induced smooth muscle growth and hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene
Greenberg, M. E., & Ziff, E. B. (1984) · Nature · doi:10.1038/311433a0 · Cited by 3,064
Induction of c-fos gene and protein by growth factors precedes activation of c-myc
Müller, R., Bravo, R., Burckhardt, J., & Curran, T. (1984) · Nature · doi:10.1038/312716a0 · Cited by 1,369
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Greenberg, M. E., Greene, L. A., & Ziff, E. B. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38689-1 · Cited by 875
Betsholtz, C., Johnsson, A., Heldin, C.-H., Westermark, B., Lind, P., Urdea, M. S., Eddy, R., Shows, T. B., Philpott, K., Mellor, A. L., et al. (1986) · Nature · doi:10.1038/320695a0 · Cited by 781
Heldin, C. H., Bäckström, G., Ostman, A., Hammacher, A., Rönnstrand, L., Rubin, K., Nistér, M., & Westermark, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02955.x · Cited by 498
Folkow, B., Hallbäck, M., Lundgren, Y., Sivertsson, R., & Weiss, L. (1972) · Spontaneous Hypertension · doi:10.1007/978-3-642-65441-1_23 · Cited by 497
Cultured endothelial cells produce a platelet-derived growth factor-like protein
DiCorleto, P. E., & Bowen-Pope, D. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.7.1919 · Cited by 497
Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas
Stanton, L. W., Watt, R., & Marcu, K. B. (1983) · Nature · doi:10.1038/303401a0 · Cited by 481
Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.
Holt, J. T., Gopal, T. V., Moulton, A. D., & Nienhuis, A. W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4794 · Cited by 439
Walker, L. N., Bowen-Pope, D. F., Ross, R., & Reidy, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.19.7311 · Cited by 391
Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.
Nishikura, K., & Murray, J. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.639 · Cited by 372
Functional angiotensin II receptors in cultured vascular smooth muscle cells.
Gunther, S., Alexander, R. W., Atkinson, W. J., & Gimbrone, M. A. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.2.289 · Cited by 346
Owens, G. K., & Schwartz, S. M. (1982) · Circulation Research · doi:10.1161/01.res.51.3.280 · Cited by 310
Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro
Campbell-Boswell, M., & Robertson, A. L. (1981) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(81)90066-6 · Cited by 305
Significance of the vascular renin-angiotensin pathway.
Dzau, V. J. (1986) · Hypertension · doi:10.1161/01.hyp.8.7.553 · Cited by 294
Self-citationNuclear Localization and DNA Binding Properties of a Protein Expressed by Human c- myc Oncogene
Persson, H., & Leder, P. (1984) · Science · doi:10.1126/science.6463648 · Cited by 281
Proto-oncogene fos: Complex but versatile regulation
Verma, I. M., & Sassone-Corsi, P. (1987) · Cell · doi:10.1016/0092-8674(87)90115-2 · Cited by 280
Nilsson, J., Sjölund, M., Palmberg, L., Thyberg, J., & Heldin, C. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4418 · Cited by 240
Owens, G. K. (1987) · Hypertension · doi:10.1161/01.hyp.9.2.178 · Cited by 227
Culture of quiescent arterial smooth muscle cells in a defined serum‐free medium
Libby, P., & O'Brien, K. V. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041150217 · Cited by 221
Mulvany, M. J., Baandrup, U., & Gundersen, H. J. (1985) · Circulation Research · doi:10.1161/01.res.57.5.794 · Cited by 188
Sejersen, T., Betsholtz, C., Sjölund, M., Heldin, C., Westermark, B., & Thyberg, J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6844 · Cited by 158
Campbell, D. J., & Habener, J. F. (1987) · Endocrinology · doi:10.1210/endo-121-5-1616 · Cited by 150
Kawahara, Y., Sunako, M., Tsuda, T., Fukuzaki, H., Fukumoto, Y., & Takai, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90485-8 · Cited by 144
Localization of angiotensinogen messenger RNA in rat aorta.
Cassis, L. A., Lynch, K. R., & Peach, M. J. (1988) · Circulation Research · doi:10.1161/01.res.62.6.1259 · Cited by 144
Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall.
Naftilan, A. J., Zuo, W. M., Inglefinger, J., Ryan, T. J., Pratt, R. E., & Dzau, V. J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115133 · Cited by 138
Self-citationKindy, M. S., & Sonenshein, G. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67172-8 · Cited by 129
JMulvany, M., UBaandrup, & JGundersen, H. (1985) · Circulation Research · Cited by 69
Cited by
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Self-citation
Metadata
- Authors
- Naftilan, A. J., Pratt, R. E., & Dzau, V. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-04-01
- Volume
- 83
- Issue
- 4
- Pages
- 1419-1424
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1990132316
- Cited by
- 623
- References
- 31
- FWCI
- 36.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.